Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Publications section wording was updated to say publications are automatically filled from PubMed, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check24 days agoChange DetectedThe government funding status banner was removed from the page. Core study details and links remain unchanged.SummaryDifference0.4%

- Check38 days agoChange DetectedNo additions or deletions were detected; the page content and structure appear unchanged.SummaryDifference0.4%

- Check67 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference4%

- Check74 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the 'Back to Top' element was removed. This is a minor update affecting versioning and a small UI element, with no changes to the core content.SummaryDifference0.2%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.